Annual Report of the Company for the Financial Year 2025-26.

gaudium® IVF Delivering Motherhood Dreams September 03,2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Exchange Plaza, C-1, Block G, Bandra Mumbai – 400001, Maharashtra Kurla Complex, Bandra (E), Mumbai – 400051, Maharashtra Scrip Code – 544709 Symbol – GAUDIUMIVF ISIN: INE0P8B01020 ISIN: INE0P8B01020 Dear Sir/Madam, Subject: Annual Report for the Financial Year 2025-26 Ref: Pursuant to Regulation 34(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 We hereby inform you that the 11th (Eleventh) Annual General Meeting ("AGM") of the members of the Company scheduled to be held on Monday, September 28, 2026, at 02:00 P.M. (IST) through Video Conferencing ("VC") / Other Audio-Visual Means ("OAVM"), in compliance with the applicable provisions of the Companies Act, 2013 ("Act") and Rules made thereunder and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), and with various circulars issued by Ministry of Corporate Affairs ("MCA") from time to time, in this regard. Pursuant to Regulation 34(1) Listing Regulations, we enclose herewith the Annual Report for the Financial Year 2025- In compliance with the provisions of the Act and Listing Regulations, read with applicable circulars issued by MCA and SEBI, the Notice of 11th AGM along with Annual Report for the Financial Year 2025-26 will be sent via e-mail to members whose e-mail IDs are registered with the Company/ RTA/ Depository Participants as on the cut-off date i.e. Friday, August 28, 2026. Further, as per Regulation 36(1)(b) of Listing Regulations, a letter providing a web-link to access the Annual Report for the Financial Year 2025-26 is also being sent to those members who have not registered their email address with the Company/ RTA/ Depository Participant. The Annual Report for FY 2025-26 is also available on the website of the Company and can be accessed through the following link: https://gaudiumivfcentre.com/assets/An-rep-25-26.pdf We request you to please take the same on record. Thanking you, Yours faithfully, For and on behalf of Gaudium IVF and Women Health Limited (Formerly known as Gaudium IVF and Women Health Private Limited) Naveen Kumar Company Secretary and Compliance Officer Membership No.: A69788 Encl:. a/a Gaudium IVF and Women Health Limited (Formerlyknown asGaudium IVF andWomen Health Pvt. Ltd.) Registered Office : B1/51, Janakpuri, New Delhi- 110058 | Ph: 011-4885 8585 CIN : L851000L2015PLC278296 Email : info@gaudiumivfcentre.com Website : www.gaudiumivfcentre.com Annual Report 2025-26 Rooted in Clinical Excellence. Built to Scale. Contents Rooted in Clinical Excellence. Built to Scale. Gaudium IVF and Women Health Limited (“Company”) or (“Gaudium IVF”) began 02 Corporate 08 Journey and 12 Management Overview Milestones Message with a clear purpose: to help couples realise their hope of having a child. When Dr. Manika Khanna envisioned Gaudium IVF as an institution dedicated to the “business of hope”, that purpose became the Company’s guiding compass. Over the years, Gaudium IVF has built an end-to-end fertility care platform serving patients in India and more than 30 countries. Its clinical model combines advanced 14 Yearly 15 Key Performance 16 Operating treatments, trained teams, standardised procedures, Highlights Indicators Environment and a culture of innovation. This has led to industry- first milestones, including becoming India’s first IVF company to receive a European quality award and the first IVF chain in the country to introduce AI into infertility treatment. Further advancing its innovation-led approach, on April 01, 2026, the Company formally integrated AI-led embryology tools into clinical practice. 19 Corporate Social 22 Statutory The journey moved from a clinician’s pursuit of excellence Responsibility Reports between 2009 and 2017 to an entrepreneurial phase of expansion from 2017–18 onwards. SOP-led operations, defined organisational hierarchies, and in-house training enabled consistent standards across seven hubs and 28 spokes, supporting the transition from a founder-led enterprise to an institution-led platform. On February 27, 2026, Gaudium IVF became 82 Financial India’s first IVF company to be listed on the Statements National Stock Exchange of India Limited (“NSE”) and BSE Limited (“BSE”). The milestone marked a new phase of public accountability, institutional maturity, and stakeholder trust. 190 AGM With a proven operating model and capital raised through Notice the IPO, the Company is positioned to expand access to high-quality fertility care across Tier 1 and Tier 2 Cities in India. “Rooted in Clinical Excellence. Built to Scale.” captures this inflexion point: clinical excellence as the foundation, institutional capability as the enabler, and responsible scale as the next chapter. Corporate Overview Statutory Reports Financial Statements Corporate Overview The Gaudium IVF Story Gaudium IVF’s journey began in 2009, when Dr. Manika Khanna established its first centre in Janakpuri. Gaudium IVF and Women Health Limited was subsequently incorporated in 2015. Over the years, the Company has expanded through a hub-and-spoke model, and as Vision Mission of March 31, 2026, had a network of seven hubs and 28 spokes One Beautiful World.Boundless Gaudium. Become a world leader in fertility care, across nine states in India. empowering families worldwide. Empowering families globally to build their dreams, Gaudium stands as a symbol of hope and Empower Parenthood: Through unwavering commitment The Company offers a complete range of specialised fertility and reproductive a source of joy worldwide. to trust, compassion, and joy. healthcare services. Its advanced treatment portfolio includes In Vitro Fertilisation (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and ovulation Create Impact: By dedicating ourselves to growth, induction, designed to address a variety of infertility challenges for both men accessibility, and awareness. and women. In addition, the Company provides comprehensive gynaecological care, high-risk pregnancy management, and fertility wellness programmes for women. The Company has also been an early adopter of advanced reproductive technologies, including vitrification for egg and embryo freezing, pre-implantation genetic testing, and TESA in male infertility treatment. The super-speciality clinics of Gaudium IVF are Our Values supported by advanced amenities and leading IVF Innovation Integrity specialists, experienced embryologists, multidisciplinary care teams, and cutting-edge practices, enabling patients Continuously pioneering advancements in fertility Building trust every step of the way through open to receive comprehensive infertility treatment. care for higher success rates. communication and transparency. Compassion Personalisation Over the years, Gaudium IVF has received several awards and certifications from reputed agencies in India and Providing empathy and unwavering support Tailoring our expertise to each unique journey, for abroad. Gaudium IVF has been ranked the No. 1 IVF throughout everyone’s parenthood journey. a future filled with hope and joy. Centre in Delhi and the No. 1 IVF Centre in India by the Times Health Survey. Our Services • Fertility Treatment − IVF Treatment or IN VITRO FERTILISATION − Laser-Assisted Embryo Implantation − Intrauterine Insemination (IUI) − Infertility Surgeries − Intracytoplasmic Sperm Injection (ICSI) − Surrogacy − Polycystic Ovarian Syndrome (PCOS) • Hospital Facility at our Janakpuri Centre − Male Infertility • Pharmacy Services − Endometriosis Treatment − Ovulation Induction (OI) 02 Annual Report 2025-26 Gaudium IVF 03 Corporate Overview Statutory Reports Financial Statements Infrastructure and Facilities at the Centre Clinical Facilities Specialised Equipment • Consultation Rooms: Dedicated spaces for patient-doct [Showing first 8,000 characters — download PDF for full document]